Published in J Hypertens on August 01, 2011
Study MIPAE - Melatonin and Essential Arterial Hypertension (MIPAE) | NCT05257291
The pathobiology of vascular dementia. Neuron (2013) 3.07
Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol (2012) 2.17
Aortic Stiffness and the Risk of Incident Mild Cognitive Impairment and Dementia. Stroke (2016) 1.43
Hypertension: a harbinger of stroke and dementia. Hypertension (2013) 1.30
Cerebral hemodynamics in normal aging: central artery stiffness, wave reflection, and pressure pulsatility. J Cereb Blood Flow Metab (2014) 1.09
Arterial stiffness and influences of the metabolic syndrome: a cross-countries study. Atherosclerosis (2014) 0.98
Early childhood poverty, immune-mediated disease processes, and adult productivity. Proc Natl Acad Sci U S A (2012) 0.95
Effects of Age and Functional Status on the Relationship of Systolic Blood Pressure With Mortality in Mid and Late Life: The ARIC Study. J Gerontol A Biol Sci Med Sci (2015) 0.94
Cerebral blood flow in Alzheimer's disease. Vasc Health Risk Manag (2012) 0.91
Effects of Arterial Stiffness on Brain Integrity in Young Adults From the Framingham Heart Study. Stroke (2016) 0.89
Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease. Acta Neuropathol Commun (2014) 0.86
Bringing prevention in geriatrics: evidences from cardiovascular medicine supporting the new challenge. Exp Gerontol (2012) 0.83
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. Biochim Biophys Acta (2015) 0.82
Cancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposure. BMC Cancer (2012) 0.82
Gradual cerebral hypoperfusion in spontaneously hypertensive rats induces slowly evolving white matter abnormalities and impairs working memory. J Cereb Blood Flow Metab (2015) 0.80
Arterial stiffness and cognitive function in the elderly. J Alzheimers Dis (2014) 0.79
Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy. Acta Neuropathol (2016) 0.79
The impact of cerebrovascular aging on vascular cognitive impairment and dementia. Ageing Res Rev (2016) 0.77
Arterial Hypertension Aggravates Innate Immune Responses after Experimental Stroke. Front Cell Neurosci (2015) 0.76
The Age-Dependent Relationship between Blood Pressure and Cognitive Impairment: A Cross-Sectional Study in a Rural Area of Xi'an, China. PLoS One (2016) 0.75
Pulse wave encephalopathy. J Hypertens (2012) 0.75
High daytime and nighttime ambulatory pulse pressure predict poor cognitive function and mild cognitive impairment in hypertensive individuals. J Cereb Blood Flow Metab (2016) 0.75
Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study. Int J Cardiol (2016) 0.75
Cardiac ventricular dimensions predict cognitive decline and cerebral blood flow abnormalities in aging men. BMC Geriatr (2013) 0.75
Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years. J Am Heart Assoc (2017) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. BMJ (2010) 4.42
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. Cancer (2010) 2.90
[Fat intake and cardiovascular health--are we completely malinformed?]. Lakartidningen (2007) 2.73
Ambulatory arterial stiffness index does not accurately assess arterial stiffness. J Hypertens (2012) 2.71
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62
Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J (2009) 2.58
Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension (2008) 2.31
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24
Oxysterols direct immune cell migration via EBI2. Nature (2011) 2.19
The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care (2003) 2.16
[Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study]. Lakartidningen (2006) 2.02
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02
Carotid-femoral pulse wave velocity assessment by two different methods: implications for risk assessment. J Hypertens (2015) 1.98
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens (2007) 1.86
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation (2011) 1.77
FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes (2011) 1.75
Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis (2010) 1.75
Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes. J Clin Endocrinol Metab (2009) 1.72
Blood pressure and obesity exert independent influences on pulse wave velocity in youth. Hypertension (2012) 1.70
Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease. Menopause (2011) 1.66
Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth. Hypertension (2009) 1.64
A matter of heart: the general practitioner consultation in an evidence-based world. Scand J Prim Health Care (2003) 1.63
Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Menopausal complaints are associated with cardiovascular risk factors. Hypertension (2008) 1.58
Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res (2005) 1.53
Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase. J Hypertens (2004) 1.52
Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age. Hypertension (2014) 1.52
Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens (2009) 1.50
Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care (2010) 1.50
Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register. Diabetes Care (2007) 1.50
Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens (2012) 1.49
Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients. J Hypertens (2013) 1.49
Heart rate variability and functional outcome in ischemic stroke: a multiparameter approach. J Hypertens (2013) 1.46
Smoking as a modifier of the systolic blood pressure-induced risk of cardiovascular events and mortality: a population-based prospective study of middle-aged men. J Hypertens (2002) 1.45
Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD. Scand J Gastroenterol (2014) 1.45
Plasma copeptin and the risk of diabetes mellitus. Circulation (2010) 1.44
Physicians' degree of motivation regarding their perception of hypertension, and blood pressure control. J Hypertens (2010) 1.43
2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) (2016) 1.42
Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care (2008) 1.41
The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements. Blood Press (2008) 1.40
Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive Project. J Hypertens (2014) 1.39
Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. J Hypertens (2013) 1.39
[Blood pressure target 130/80 Hg in type 2 diabetes should be reconsidered. Three new studies support systolic pressure 140 mm Hg]. Lakartidningen (2011) 1.39
[Renal function as a prognostic marker of mortality in heart failure]. Med Clin (Barc) (2009) 1.38
Physical Activity and Mortality in Individuals With Diabetes Mellitus: A Prospective Study and Meta-analysis. Arch Intern Med (2012) 1.38
[Swedish physicians were guests in Nazi elite school]. Lakartidningen (2009) 1.37
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens (2012) 1.37
Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J (2011) 1.31
Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus. Am J Epidemiol (2011) 1.22
Characterization of the influence of vildagliptin on model-assessed -cell function in patients with type 2 diabetes and mild hyperglycemia. J Clin Endocrinol Metab (2007) 1.16
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int (2009) 1.16
Lower educational level is a predictor of incident type 2 diabetes in European countries: the EPIC-InterAct study. Int J Epidemiol (2012) 1.15
Age at menarche and type 2 diabetes risk: the EPIC-InterAct study. Diabetes Care (2013) 1.13
Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens (2013) 1.12
The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study. Diabetes Care (2013) 1.10
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis (2013) 1.08
Obesity, survival, and hospital costs-findings from a screening project in Sweden. Value Health (2005) 1.08
Reference values for central blood pressure. J Am Coll Cardiol (2014) 1.08
Cardiovascular event risk in relation to dietary fat intake in middle-aged individuals: data from The Malmö Diet and Cancer Study. Eur J Cardiovasc Prev Rehabil (2007) 1.07
[In Process Citation]. Lakartidningen (2015) 1.06
Distance measurements for the assessment of carotid to femoral pulse wave velocity. J Hypertens (2009) 1.06